Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPlastic/Reconstructive SurgeryModa Health Lymphedema Coverage Update | OpenPayer
    Ask Trek AI about this page
    CurrentModa HealthPolicy N/A

    Treatment of Lymphedema

    Customize your policy alerts

    Sign up for all Moda Health policy alerts

    Know when Moda Health releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Medical-necessity and prior-authorization criteria for surgical treatment of chronic lymphedema, including excisional procedures, vascularized lymph node transplantation, and microsurgical treatment.

    Policy Summary
    PayerModa Health
    PolicyTreatment of Lymphedema
    Policy CodePolicy N/A
    Change TypeAdministrative annual reviewno material changes
    Effective DateNov 1, 2026
    Last ReviewOct 28, 2026
    Next Review DateN/A
    Key ActionSubmit prior authorization with clinical chart notes for covered lymphedema treatment services.
    SourceLink
    POLICY UPDATE CHANGES

    The annual review documented grammar updates and reference updates without content changes.

    3Surgical treatment categories with criteria
    3 monthsRequired conservative-treatment trial
    Stage IIIRequired stage for excisional procedures

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    II or III
    Eligible stages for lymph node transplantation
    5Microsurgical contraindication categories

    Medical Necessity Criteria

    Excisional procedures

    Excisional procedures, including limb debulking and liposuction, are medically necessary when ALL of the following are met:

    Required criteria

    • Clinical diagnosis: Signs and symptoms consistent with lymphedema as determined by a certified lymphedema therapist
    • Disease stage: Diagnosis of stage III lymphedema according to International Society of Lymphology stagingStage III
    • Functional impact: Physical functional impairment
    • Failure of conservative treatment

      • Required treatments: Compression garments and manual lymph drainage

    Vascularized lymph node transplant

    Vascularized lymph node transplant may be considered when ALL of the following are met:

    Required criteria

    • Clinical diagnosis: Signs and symptoms consistent with lymphedema as determined by a certified lymphedema therapist
    • Disease stage: Diagnosis of stage II or III lymphedema by International Society of Lymphology standardsStage II or III
    • Qualifying clinical impact

      • Functional impairment: Physical functional impairment, such as difficulty performing activities of daily living or difficulty ambulating

    Microsurgical treatment

    Microsurgical treatment, including lymphovenous bypass and lymph node-to-vein anastomosis, is considered a treatment option when ALL of the following are met:

    Required criteria

    • Clinical diagnosis: Signs and symptoms consistent with lymphedema as determined by a certified lymphedema therapist
    • Functional impairment: Physical functional impairment, including difficulty performing activities of daily living
    • Skin-condition history: History of chronic or recurrent skin conditions, such as ulcerations
    • Pain or weakness in the affected extremity

    Transient lymphedema is a contraindication to microsurgical treatment. This includes swelling that meets the lymphedema threshold and occurs within six months after the last oncologic treatment.

    Lipedema without lymphatic dysfunction is a contraindication to microsurgical treatment.

    Microsurgical treatment is contraindicated when uncontrolled comorbidities are present. Examples include venous disease such as deep-vein thrombosis or superior vena cava syndrome, congestive heart failure, medication-induced swelling, liver disease including cirrhosis or hypoproteinemia, and nephropathy including end-stage renal disease.

    Pregnancy is a contraindication to microsurgical treatment.

    Active infection of the affected extremity, including cellulitis or erysipelas, is a contraindication to microsurgical treatment.

    Covered Codes and Clinical Coding Requirements

    Covered CPT or HCPC CodesCPT | HCPCSCovered
    15830Excision, excessive skin and subcutaneous tissue (includes lipectomy); abdomen, infra-umbilical panniculectomy.
    15832Thigh.
    15833Leg.
    15834Hip.
    15835Buttock.
    15836Arm.
    15837Forearm or hand.
    15838Submental fat pad.
    15839Other area.
    15847Excision, excessive skin and subcutaneous tissue (includes lipectomy), abdomen (e.g., abdominoplasty) (includes umbilical transposition and fascial plication) (List separately in addition to code for primary procedure).
    1–10 of 16
    1/2
    Conservative or Medical-Management Treatment
    Minimum durationAt least three consecutive months
    Applicable treatmentConservative or medical management
    Required responsePoor or no response to treatment is required for applicable surgical procedures
    Lymphoscintigraphy
    Minimum delayed transitOne hour
    Upper-extremity lymphedemaAssess transit to the first-level axillary lymph nodes
    Lower-extremity lymphedema

    Authorization and Documentation Requirements

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required for the lymphedema procedures addressed by this policy. Submit the authorization request before treatment is performed and include the clinical documentation needed to establish medical necessity.

    Documentation Required

    Three-Month Conservative Treatment Requirement

    Document failure of conservative or medical management for at least three consecutive months before requesting coverage for excisional, vascularized lymph node transplant, or microsurgical treatment. The treatment history should identify therapies used, such as compression garments or bandaging, manual lymphatic drainage, complete decongestive therapy, and pneumatic compression.

    Documentation Required

    Clinical Chart Notes Required

    Lymphedema Overview

    Lymphedema is swelling caused by accumulation of lymph fluid when lymphatic drainage is obstructed or overwhelmed. It may be primary, resulting from a congenital or inherited lymphatic malformation, or secondary, resulting from injury, malignancy, lymph-node excision, radiation, or other cancer treatment. Clinical manifestations may include extremity or proximal swelling, restricted range of motion, skin changes, pain, altered sensation, limb heaviness, and difficulty fitting clothing.

    Lymphedema Staging and Key Terms

    Stage 0 (Subclinical) Lymphedema
    SwellingNot evident
    SymptomsMost patients are asymptomatic
    Lymphatic transportImpaired despite the absence of evident swelling
    Stage I (Mild) Lymphedema
    Fluid responseAccumulation usually subsides within 24 hours with limb elevation
    EdemaSoft and may pit
    Dermal fibrosisNo evidence of dermal fibrosis
    Policy Summary
    PayerModa Health
    PolicyTreatment of Lymphedema
    Policy CodePolicy N/A
    Change TypeAdministrative annual reviewno material changes
    Effective DateNov 1, 2026
    Last ReviewOct 28, 2026
    Next Review DateN/A
    Key ActionSubmit prior authorization with clinical chart notes for covered lymphedema treatment services.
    SourceLink
    On This Page
    Medical Necessity CriteriaCovered Codes and Clinical Coding RequirementsAuthorization and Documentation RequirementsLymphedema OverviewLymphedema Staging and Key Terms
    Pain or weakness: Significant pain or weakness in the affected extremity or extremities
  1. Skin conditions: History of chronic or recurrent skin conditions, such as cellulitis or ulcerations
  2. Failure of medical management: Lack of response to medical managementAt least three consecutive months

    Examples include compression therapy such as bandaging, manual lymphatic drainage, complete decongestive therapy, and pneumatic compression.

  3. Qualified facility: Surgery is performed at a certified lymphedema center of excellence
  4. Failure of conservative treatment: Failure to respond to conservative treatment, such as manual lymphatic drainage or compression garmentsAt least three consecutive months
  5. Quantitative lymphatic abnormality

    • MR lymphangiogram: Residual lymphatic channels demonstrated by MR lymphangiogram
    • Bioimpedance abnormality differential consistent with lymphedema
    • Lymphoscintigraphy showing a minimum one-hour delayed transit time to first-level lymph nodes or a dermal backflow patternMinimum one-hour delayed transit time

      For upper-extremity lymphedema, assess axillary lymph nodes; for lower-extremity lymphedema, assess inguinal lymph nodes.

  6. Qualified facility: Surgery is performed at a certified lymphedema center of excellence
  7. No contraindication: None of the listed contraindications is present

    Contraindications include transient lymphedema occurring up to six months after the last oncologic treatment, lipedema without lymphatic dysfunction, uncontrolled comorbidities, pregnancy, and active infection of the affected extremity.

  8. Assess transit to the first-level inguinal lymph nodes

    Include clinical chart notes with every prior authorization request. The notes must support the diagnosis, applicable lymphedema stage, functional and other symptoms, treatment history, and the specific procedure requested.

    Documentation Required

    Clinical and Treatment-History Documentation

    Clinical and treatment-history documentation must establish the findings relevant to the requested procedure and show that qualifying treatment has been attempted.

    • Signs and symptoms consistent with lymphedema, as determined by a certified lymphedema therapist.
    • ISL stage: stage III for excisional procedures; stage II or III for vascularized lymph node transplant; and the documented stage for microsurgical treatment.
    • Physical functional impairment, including difficulty performing activities of daily living or ambulating, when required.
    • For vascularized lymph node transplant or microsurgery, document significant pain or weakness and a history of chronic or recurrent skin conditions such as cellulitis or ulcerations, as applicable.
    • Document at least three consecutive months of conservative or medical management and the response to that treatment.
    • For microsurgery, include the qualifying quantitative test result: residual lymphatic channels on MR lymphangiogram; bioimpedance differential abnormality consistent with lymphedema; or lymphoscintigraphy showing at least one-hour delayed transit to the first-level axillary or inguinal lymph nodes, or a dermal backflow pattern.
    • Document that surgery will be performed at a certified lymphedema center of excellence when required.
    Denial Risk

    Excisional Procedure Criteria Not Met

    An excisional procedure, including limb debulking or liposuction, is not supported when the required chronic refractory lymphedema criteria are absent.

    • No signs or symptoms consistent with lymphedema documented by a certified lymphedema therapist.
    • No diagnosis of ISL stage III lymphedema.
    • No physical functional impairment.
    • No advanced-stage disease with poor or no response to at least three consecutive months of conservative treatment, including compression garments and manual lymph drainage.
    Denial Risk

    Vascularized Lymph Node Transplant Criteria Not Met

    Vascularized lymph node transplant is not supported when the required symptoms, stage, treatment response, or facility criteria are absent.

    • No signs and symptoms consistent with lymphedema documented by a certified lymphedema therapist.
    • No ISL stage II or III diagnosis.
    • None of the qualifying conditions is documented: physical functional impairment; significant pain or weakness in the affected extremity; or chronic or recurrent skin conditions such as cellulitis or ulcerations.
    • No lack of response to at least three consecutive months of medical management.
    • Surgery is not planned at a certified lymphedema center of excellence.
    Denial Risk

    Microsurgical Treatment Contraindication or Criteria Failure

    Microsurgical treatment, including lymphovenous bypass or lymph node-to-vein anastomosis, is not supported when required clinical, testing, facility, or safety criteria are absent.

    • No signs and symptoms consistent with lymphedema documented by a certified lymphedema therapist; no physical functional impairment; no chronic or recurrent skin condition; or no pain or weakness in the affected extremity.
    • No failure to respond to at least three consecutive months of conservative treatment.
    • No qualifying objective testing: MR lymphangiogram showing residual lymphatic channels, abnormal bioimpedance differential consistent with lymphedema, or qualifying lymphoscintigraphy findings.
    • Surgery is not planned at a certified lymphedema center of excellence.
    • Treatment is contraindicated for transient lymphedema occurring up to six months after the last oncologic treatment, lipedema without lymphatic dysfunction, uncontrolled comorbidities (including venous disease, congestive heart failure, medication-induced swelling, liver disease, or nephropathy), pregnancy, or active infection of the affected extremity such as cellulitis or erysipelas.
    Stage II (Moderate) Lymphedema
    Response to elevationDoes not resolve with limb elevation alone
    PittingPitting is manifest
    SeverityModerate lymphedema
    Stage III (Severe) Lymphedema
    Clinical descriptionLymphostatic elephantiasis
    PittingPitting can be absent
    SkinSkin has trophic changes
    Certified Lymphedema Therapist
    QualificationA clinician with certification in lymphedema therapy
    Primary roleDetermines whether signs and symptoms are consistent with lymphedema
    Policy relevanceThe therapist's determination supports the clinical diagnosis used for treatment criteria